| Literature DB >> 33651238 |
Mahsa Pourhamzeh1, Fahimeh Ghasemi Moravej2, Mehrnoosh Arabi1,3, Elahe Shahriari4, Soraya Mehrabi1,4, Richard Ward5, Reza Ahadi6, Mohammad Taghi Joghataei7,8.
Abstract
The serotonergic system extends throughout the central nervous system (CNS) and the gastrointestinal (GI) tract. In the CNS, serotonin (5-HT, 5-hydroxytryptamine) modulates a broad spectrum of functions, including mood, cognition, anxiety, learning, memory, reward processing, and sleep. These processes are mediated through 5-HT binding to 5-HT receptors (5-HTRs), are classified into seven distinct groups. Deficits in the serotonergic system can result in various pathological conditions, particularly depression, schizophrenia, mood disorders, and autism. In this review, we outlined the complexity of serotonergic modulation of physiologic and pathologic processes. Moreover, we provided experimental and clinical evidence of 5-HT's involvement in neuropsychiatric disorders and discussed the molecular mechanisms that underlie these illnesses and contribute to the new therapies.Entities:
Keywords: 5-HT; Mood Disorders; Nervous System Diseases; SSRI; Serotonin pathway
Mesh:
Substances:
Year: 2021 PMID: 33651238 DOI: 10.1007/s10571-021-01064-9
Source DB: PubMed Journal: Cell Mol Neurobiol ISSN: 0272-4340 Impact factor: 5.046